Daruka Mahadevan

Efficacy of Lenalidomide in Myelodysplastic Syndromes

Alan F. List, S. Kurtin, Denise J. Roe et al. · New England Journal of Medicine · 2005 · 876 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Lawrence Fong, Andrew Hotson, John D. Powderly et al. · Cancer Discovery · 2019 · 339 citations · Full text

Medicine, Immunology, Oncology +17

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

Jonathan W. Friedberg, Daruka Mahadevan, Erin Cebula et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Medicine, Hematology, Pharmacology +17

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

Daruka Mahadevan, E. Gabriela Chiorean, Wayne B. Harris et al. · European Journal of Cancer · 2012 · 134 citations

Medicine, Oncology, Pharmacology +11

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Daruka Mahadevan, Catherine Spier, Kimiko Della Croce et al. · Molecular Cancer Therapeutics · 2005 · 95 citations

Medicine, Cancer Biology, Oncology +17